Pharmacology of Adrenergic Modulators

A critical concept in pharmacology is affinity—the strength with which a drug or neurotransmitter binds to a receptor. The different families show distinct hierarchies of affinity for the primary ligands: Adrenaline (A), Noradrenaline (NA), and Isoprenaline.

• $\alpha$ Receptors: These show a higher affinity for Adrenaline than for Noradrenaline, which in turn has a higher affinity than Isoprenaline. $\text{Affinity: } A > NA > \text{Isoprenaline}$
• $\beta$ Receptors: These show a higher affinity for Isoprenaline than for Adrenaline or Noradrenaline. $\text{Affinity: } \text{Isoprenaline} > A > NA$

Physiological Responses of the SNS

Because different receptors are located in different tissues, the SNS can simultaneously increase heart rate while relaxing the lungs. This allows for a coordinated "emergency" response.

Adrenergic Modulators: Agonists and Antagonists

Drugs that influence the SNS are classified based on whether they mimic or block the natural neurotransmitter.

1. Adrenergic Agonists (Sympathomimetics)

These drugs mimic the effects of the SNS. They can be mixed (acting on both $\alpha$ and $\beta$ receptors) or selective (acting on only one subtype).

• Mixed $\alpha/\beta$ Agonists: Used in emergencies like anaphylactic shock or cardiac arrest to provide systemic stimulation.
• $\alpha$-Selective Agonists:
  • $\alpha_1$ agonists are used for nasal decongestion.
  • $\alpha_2$ agonists act as "sympatholytics" by activating pre-synaptic auto-inhibitory receptors to reduce sympathetic outflow, often used for hypertension.
• $\beta$-Selective Agonists:
  • $\beta_1$ agonists (heart-selective) increase heart rate and contraction force, used in congestive heart failure.
  • $\beta_2$ agonists (lung-selective) cause bronchodilation, making them essential for asthma therapy.

2. Adrenergic Antagonists (Sympatholytics)

These drugs "lyse" or block the effects of the SNS by preventing noradrenaline from activating the receptors.

• $\alpha$-Antagonists: Primarily used to treat hypertension or Benign Prostatic Hyperplasia by blocking $\alpha_1$ receptors.
• $\beta$-Antagonists:
  • Non-selective $\beta$-blockers: Block both $\beta_1$ and $\beta_2$ receptors. While useful for hypertension or angina, they can cause side effects like bronchoconstriction because they block the $\beta_2$ receptors in the lungs.
  • $\beta_1$-Selective $\beta$-blockers: Often called "heart-selective" agents. These are preferred for patients with respiratory issues (like asthma) because they target the heart ($\beta_1$) without causing constriction in the lungs ($\beta_2$).

Clinical Correlation: When choosing a beta-blocker for a patient with asthma, always look for $\beta_1$-selectivity. A non-selective blocker could trigger a life-threatening bronchospasm by blocking the $\beta_2$ receptors that normally keep the airways open.